Montaner, J <br/><br/>
Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment.  [electronic resource] 

 -  Stroke  Aug 2001 
 - 1759-66 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1524-4628 
<br/><br/><label>Standard No.: </label>10.1161/01.str.32.8.1759  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adult<br/>Aged<br/>Disease Progression<br/>Female<br/>Humans<br/>Infarction, Middle Cerebral Artery--complications<br/>Logistic Models<br/>Male<br/>Matrix Metalloproteinase 2--blood<br/>Matrix Metalloproteinase 9--blood<br/>Middle Cerebral Artery--diagnostic imaging<br/>Prospective Studies<br/>Severity of Illness Index<br/>Stroke--complications<br/>Time Factors<br/>Tomography, X-Ray Computed<br/>Ultrasonography, Doppler, Transcranial